Abeona Therapeutics Inc.: shareholders and insiders

ABEONASDAQHealthcare · Pharmaceutical Preparations

Price

$2.42

November 20, 2026Market cap $138M

What Ploutos Investor adds for Abeona Therapeutics

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 14 fiscal years, from 2010
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.

Insiders and their shares

Purchases and sales by officers and directors from Nov 22, 2025 to Nov 16, 2026, from their own Form 4 filings.

18 Form 4s

Bought on the market

$34.3K

1 person

Sold on the market

$3.5M

9 people

From Nov 22, 2025 to Nov 22, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

  • Under a set plan19%
  • The rest81%

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 22, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·bought $34.3K by 1 person·sold $3.4M by 9 people

  • 2025: no buys, sold $132.8K by 1 person
  • 2026: bought $34.3K by 1 person, sold $3.4M by 9 people
  • Nov 13, 2026Faith L. CharlesDirector
    Kind
  • Sep 29, 2026Vishwas SeshadriChief Executive Officer
    Kind
  • Sep 29, 2026Joseph Walter VazzanoChief Financial Officer
    Kind
  • Sep 29, 2026Brendan M. O'MalleySVP, Chief Legal Officer
    Kind
  • Sep 29, 2026Madhav VasanthavadaChief Commercial Officer
    Kind
  • Sep 1, 2026Mark AlvinoDirector
    Kind
  • Jul 21, 2026Joseph Walter VazzanoChief Financial Officer
    Kind
  • Jul 9, 2026Joseph Walter VazzanoChief Financial Officer
    Kind
  • Jul 9, 2026Vishwas SeshadriChief Executive Officer
    Kind
  • Jul 9, 2026Brendan M. O'MalleySVP, Chief Legal Officer
    Kind
  • Jul 9, 2026Madhav VasanthavadaChief Commercial Officer
    Kind
  • Jun 30, 2026Leila AllandDirector
    Kind
  • Jun 16, 2026Madhav VasanthavadaChief Commercial Officer
    Kind
  • Jun 15, 2026Christine Berni SilversteinDirector
    Kind
  • Jun 9, 2026Brendan M. O'MalleySVP, Chief Legal Officer
    Kind
  • Jun 9, 2026Joseph Walter VazzanoChief Financial Officer
    Kind10b5-1
  • Jun 9, 2026Joseph Walter VazzanoChief Financial Officer
    Kind10b5-1
  • Jun 9, 2026Madhav VasanthavadaChief Commercial Officer
    Kind
  • Jun 9, 2026Vishwas SeshadriChief Executive Officer
    Kind
  • Jun 8, 2026Brendan M. O'MalleySVP, Chief Legal Officer
    Kind
  • Jun 8, 2026Joseph Walter VazzanoChief Financial Officer
    Kind10b5-1
  • Jun 8, 2026Madhav VasanthavadaChief Commercial Officer
    Kind
  • Jun 8, 2026Vishwas SeshadriChief Executive Officer
    Kind
  • May 22, 2026Mark Alvino
    Kind
  • May 15, 2026Eric Crombez
    Kind10b5-1

From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 9, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Insiders and their shares

Every buy and sale by ABEO's officers and directors from 2005 up to November 21, 2025, 21 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

7 Holders over 5%1 On a 13DNov 12, 2026 Latest filing
  • Nantahala Capital Management, LLCwith 2 more persons
    Share of class9.99%
  • Daniel Kaufman
    Share of class7.30%
  • James Russell Revocable Trustwith 1 more person
    Share of class6.10%
  • Nantahala Capital Partners Limited Partnership
    Share of class5.82%
  • BlackRock, Inc.
    Share of class5.80%
  • Orin Hirschmanwith 1 more person
    Share of class5.40%
  • Funicular Funds, LPwith 2 more persons
    Share of class5.30%

What the holders on a 13D state as their purpose

From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.

  • James Russell Revocable Trust6.1%From the filing of Oct 23, 2026

    The Reporting Persons originally acquired the Shares for investment purposes and reported their beneficial ownership on Schedule 13G. Over time, based on their review of the Issuer's public filings, press releases and other public communications, the Reporting Persons became concerned regarding the Issuer's operational execution, the consistency of management's public statements with subsequent operating results, and the Issuer's governance. Beginning in May 2026, the Reporting Persons communicated their concerns (as a shareholder in an informal manner), to the Issuer's management and board of directors (the "Board"). On October 14, 2026, Mr. Russell met electronically with two members…

    From the filing of Oct 23, 2026
Fell to 5% or less (4)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Montanova Capital, LLC0.90%Aug 14, 202613G/A
  • The Vanguard Group0.00%Mar 26, 202613G/A
  • Adage Capital Management, L.P.0.00%Feb 12, 202613G/A
  • Integrated Core Strategies (US) LLC1.70%May 1, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Citadel Advisors (Griffin)
    In the quarter-93%
  • Millennium Mgmt (Englander)
    In the quarter-22%
  • D.E. Shaw
    In the quarter-80%
  • AQR Capital
    In the quarter-36%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 30.2% of its shares outstanding were held short, +2.0% since the report before.

Shares held short
17.21M
30.2%
Since the report before16.88M on Sep 30, 2026
+2.0%
12.7
1.36M
More days to cover thanof 4,578 US-listed companies with enough volume
96%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 630.4K
  • Nov 15, 2023: Shares held short 603.7K
  • Nov 30, 2023: Shares held short 549.0K
  • Dec 15, 2023: Shares held short 429.2K
  • Dec 29, 2023: Shares held short 603.9K
  • Jan 12, 2024: Shares held short 662.0K
  • Jan 31, 2024: Shares held short 778.5K
  • Feb 15, 2024: Shares held short 1.56M
  • Feb 29, 2024: Shares held short 1.64M
  • Mar 15, 2024: Shares held short 1.70M
  • Mar 28, 2024: Shares held short 1.99M
  • Apr 15, 2024: Shares held short 2.06M
  • Apr 30, 2024: Shares held short 3.35M
  • May 15, 2024: Shares held short 3.02M
  • May 31, 2024: Shares held short 2.29M
  • Jun 14, 2024: Shares held short 2.65M
  • Jun 28, 2024: Shares held short 3.36M
  • Jul 15, 2024: Shares held short 3.08M
  • Jul 31, 2024: Shares held short 2.97M
  • Aug 15, 2024: Shares held short 3.03M
  • Aug 30, 2024: Shares held short 2.84M
  • Sep 13, 2024: Shares held short 2.63M
  • Sep 30, 2024: Shares held short 2.67M
  • Oct 15, 2024: Shares held short 2.77M
  • Oct 31, 2024: Shares held short 2.64M
  • Nov 15, 2024: Shares held short 2.63M
  • Nov 29, 2024: Shares held short 2.58M
  • Dec 13, 2024: Shares held short 2.53M
  • Dec 31, 2024: Shares held short 2.55M
  • Jan 15, 2025: Shares held short 2.66M
  • Jan 31, 2025: Shares held short 2.48M
  • Feb 14, 2025: Shares held short 2.47M
  • Feb 28, 2025: Shares held short 2.52M
  • Mar 14, 2025: Shares held short 2.39M
  • Mar 31, 2025: Shares held short 2.21M
  • Apr 15, 2025: Shares held short 2.76M
  • Apr 30, 2025: Shares held short 5.45M
  • May 15, 2025: Shares held short 5.89M
  • May 30, 2025: Shares held short 6.01M
  • Jun 13, 2025: Shares held short 6.46M
  • Jun 30, 2025: Shares held short 8.29M
  • Jul 15, 2025: Shares held short 8.48M
  • Jul 31, 2025: Shares held short 8.42M
  • Aug 15, 2025: Shares held short 8.81M
  • Aug 29, 2025: Shares held short 9.03M
  • Sep 15, 2025: Shares held short 8.73M
  • Sep 30, 2025: Shares held short 8.63M
  • Oct 15, 2025: Shares held short 9.19M
  • Oct 31, 2025: Shares held short 10.35M
  • Nov 14, 2025: Shares held short 13.59M
  • Nov 28, 2025: Shares held short 13.81M
  • Dec 15, 2025: Shares held short 14.00M
  • Dec 31, 2025: Shares held short 13.25M
  • Jan 15, 2026: Shares held short 13.82M
  • Jan 30, 2026: Shares held short 14.33M
  • Feb 13, 2026: Shares held short 13.69M
  • Feb 27, 2026: Shares held short 13.05M
  • Mar 13, 2026: Shares held short 15.10M
  • Mar 31, 2026: Shares held short 15.84M
  • Apr 15, 2026: Shares held short 16.47M
  • Apr 30, 2026: Shares held short 16.49M
  • May 15, 2026: Shares held short 14.47M
  • May 29, 2026: Shares held short 14.39M
  • Jun 15, 2026: Shares held short 14.14M
  • Jun 30, 2026: Shares held short 13.68M
  • Jul 15, 2026: Shares held short 13.23M
  • Jul 31, 2026: Shares held short 13.64M
  • Aug 14, 2026: Shares held short 14.27M
  • Aug 31, 2026: Shares held short 15.16M
  • Sep 15, 2026: Shares held short 15.75M
  • Sep 30, 2026: Shares held short 16.88M
  • Oct 15, 2026: Shares held short 17.21M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading39.7% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 39.7% of the shares in the reported trades were short sales, against 63.2% in the 14 before.

Last 14 sessionsNov 3, 2026 – Nov 20, 2026
39.7%
The 14 beforeOct 14, 2026 – Nov 2, 2026
63.2%
Change
-23.5 pts
Short sales a dayon average, of 1.67M shares
663.5K
More than atof 3,666 US-listed companies, same days
19%
Median of alleight in ten from 34.4% to 63.9%
50.5%
  • Oct 14, 2026: Short sales 76.1%
  • Oct 15, 2026: Short sales 70.9%
  • Oct 16, 2026: Short sales 73.2%
  • Oct 19, 2026: Short sales 71.7%
  • Oct 20, 2026: Short sales 46.1%
  • Oct 21, 2026: Short sales 57.5%
  • Oct 22, 2026: Short sales 37.4%
  • Oct 23, 2026: Short sales 62.7%
  • Oct 26, 2026: Short sales 53.9%
  • Oct 27, 2026: Short sales 68%
  • Oct 28, 2026: Short sales 36.2%
  • Oct 29, 2026: Short sales 62.2%
  • Oct 30, 2026: Short sales 63.7%
  • Nov 2, 2026: Short sales 71.1%
  • Nov 3, 2026: Short sales 60.1%
  • Nov 4, 2026: Short sales 54.8%
  • Nov 5, 2026: Short sales 69.2%
  • Nov 6, 2026: Short sales 60.1%
  • Nov 9, 2026: Short sales 44.5%
  • Nov 10, 2026: Short sales 45%
  • Nov 11, 2026: Short sales 39.9%
  • Nov 12, 2026: Short sales 23.5%
  • Nov 13, 2026: Short sales 25.2%
  • Nov 16, 2026: Short sales 38.1%
  • Nov 17, 2026: Short sales 58.9%
  • Nov 18, 2026: Short sales 32%
  • Nov 19, 2026: Short sales 40%
  • Nov 20, 2026: Short sales 19.2%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

3.22M Insiders' shares5.64% Of the company
  • Vishwas SeshadriChief Executive Officer
    Directly1.29M
  • Joseph Walter VazzanoChief Financial Officer
    Directly482.9K
  • Brendan M. O'MalleySVP, Chief Legal Officer
    Directly421.2K
  • Madhav VasanthavadaChief Commercial Officer
    Directly285.7K
  • Faith L. CharlesDirector
    Directly191.4K
  • Donald A. WuchterlDirector
    Directly167.9K
  • Leila AllandDirector
    Directly162.6K
  • Christine Berni SilversteinDirector
    Directly119.6K
  • Mark AlvinoDirector
    Directly62.1K
  • Eric CrombezDirector
    Directly37.3K

A lower bound: it counts only the 10 officers and directors with a market trade since Nov 23, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

9 ETFs holding it0.06% The largest weight (IWC)
  • IWCiShares Micro-Cap ETF
    Weight in the fund0.06%
  • IWNiShares Russell 2000 Value ETF
    Weight in the fund0.02%
  • FESMFidelity Enhanced Small Cap Core ETF
    Weight in the fund0.01%
  • IWMiShares Russell 2000 ETF
    Weight in the fund0.01%
  • VTWOVanguard Russell 2000 Index Fund
    Weight in the fund0.01%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%
  • ITOTiShares Core S&P Total U.S. Stock Market ETF
    Weight in the fund0.00%
  • DFASDimensional U.S. Small Cap ETF
    Weight in the fund0.00%
  • VTIVanguard Total Stock Market Index Fund
    Weight in the fund0.00%

9 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

127 Managers, Q2 2026$275M Value of their positions
  • Q3 2025: Managers 100
  • Q4 2025: Managers 104
  • Q1 2026: Managers 108
  • Q2 2026: Managers 127

Institutional investors by quarter

The fund managers holding ABEO, quarter by quarter, from Q2 2015 to Q2 2025, 41 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 127 managers held 44.53M shares, worth $275M. During the quarter 32 opened a position, 13 closed one, 41 added and 32 trimmed.

The largest holders, Q2 2026

  • Nantahala Capital Management
    In the quarter+105%
  • BlackRock
    In the quarter+4.9%
  • Cable Car Capital
    In the quarter
  • AIGH Capital Management
    In the quarter-3.6%
  • Vanguard Capital Management
    In the quarter+2.2%
  • OneDigital Investment Advisors
    In the quarter
  • AWM Investment
    In the quarter+85%
  • Geode Capital Management
    In the quarter+4.2%
  • Kennedy Capital Management
    In the quarter-1.9%
  • Goldman Sachs Group
    In the quarter+8.3%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Abeona Therapeutics's filings show?

Who buys and sells is one part of Abeona Therapeutics's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about ABEO's shareholders

Didn't find what you were looking for?

Ask us
Have ABEO's insiders bought or sold?

From Jun 9, 2026 to Nov 16, 2026 Abeona Therapeutics's insiders bought $34.3K and sold $2.0M of shares on the market. 13% of the sales were under set 10b5-1 plans.

Which well-known managers hold ABEO?

4 of the managers we track held the shares on Sep 30, 2026. The largest position was Millennium Mgmt (Englander)'s, worth $900.0K.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.